Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Out-of-pocket healthcare spending up—but remains steady as share of take-home income

The JPMorgan Chase Institute Healthcare Out-of-pocket Spending Panel (JPMCI HOSP) included 2.3 anonymized Chase customers from 18 to 64 years old between 2013 and 2016. The study found out-of-pocket spending on healthcare jumped up from $629 per family to $714—and increase of 14 percent. But healthcare remained spending remained relatively constant as a share of take-home income (1.7 percent in 2013; 1.6 percent in 2016) and total spending (1.1 percent; 1.2 percent).

Thumbnail

Radiologist sentenced to jail time for fraud

Jean-Francois H. Geschwind, MD, a radiologist who previously worked at Johns Hopkins University School of Medicine in Baltimore, has been sentenced to a year and a day in jail after pleading guilty to four counts of mail fraud back in July. He was also ordered to pay more than $580,000 in restitution.

MEDNAX acquires Connecticut-based Jefferson Radiology

MEDNAX announced Thursday it has acquired Hartford, Conn.-based Jefferson Radiology and Jefferson Imaging Associates. It was a cash transaction, and no other terms of the deal were made public.

Thumbnail

What radiologists can learn from reviewing malpractice claims data

Interpretation errors and communication failures are two of the largest issues that lead to malpractice claims in radiology, according to new research published in Diagnosis. Understanding ways to improve in these areas can help specialists “play a vital role in facilitating optimal patient care.”

Thumbnail

Does R&D for cancer drugs cost less than industry-backed estimates?

The Tufts Center for the Study of Drug Development estimates it costs $2.7 billion to bring a drug into market, taking into consideration research and development (R&D) expenditures by pharmaceutical companies. One of the main justifications for high drug prices is the substantial R&D costs to bring drugs to American consumers—but does it really cost that much?

Thumbnail

Anthem policy pushes outpatient imaging out of hospitals

Anthem made headlines this summer by pulling back from several Obamacare exchange programs, but that’s not the insurance giant’s only big policy change of 2017. The Imaging Clinical Site of Care program, administered by Anthem subsidiary AIM Specialty Health, requires outpatient MR and CT scans not considered medically necessary to be completed at a freestanding imaging facility in order to be covered.

Fujifilm announces new 10-year contract with US Dept of Defense

FUJIFIM Medical Systems U.S.A. announced Wednesday that it has agreed to a 10-year contract with the U.S. Department of Defense (DoD) and the U.S. Department of Veterans Affairs worth up to $768 million. The contract, part of the Digital Imaging Network-PACS (DIN-PACS) IV project, allows U.S. government healthcare providers to purchase and install solutions—including Synapse 5 PACS and Synapse VNA—from Fujifilm’s Synapse enterprise imaging portfolio.

MEDNAX acquires Radiology Associates of South Florida

MEDNAX announced Wednesday, Aug. 23, it has acquired Miami-based Radiology Associates of South Florida (RASF). It was a cash transaction, and no other terms of the deal have been made public.

Around the web

News of an incident is a stark reminder that healthcare workers and patients aren’t the only ones who need to be aware around MRI suites.

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.